Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 171Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Chunghwa Chemical Synthesis & Biotech. Ltd

02 1Biocon Limited

03 1CKD Bio Corporation

04 4Concord Biotech Limited

05 1DARMERICA, LLC

06 1Dasami Lab Private Limited

07 1Emcure Pharmaceuticals Limited

08 1Excella GmbH & Co. KG

09 1Formosa Laboratories, Inc.

10 1Hisun Pharmaceutical (Hangzhou) Co., Ltd.

11 1Novartis Pharmaceuticals Corporation

12 1Professional Compounding Centers of America

13 1TAPI Czech Industries s.r.o.

14 1TEVA Czech Industries s.r.o

15 1Wuxi Fortune Pharmaceutical Co.,Ltd.

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.

MYCOPHENOLATE MOFETIL

NDC Package Code : 52076-6220

Start Marketing Date : 2018-01-15

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (50kg/50kg)

Marketing Category : BULK INGREDIENT

CCSB Company Banner

03

IMCAS Asia
Not Confirmed
arrow
arrow
IMCAS Asia
Not Confirmed

MYCOPHENOLATE MOFETIL

NDC Package Code : 52972-0037

Start Marketing Date : 2011-06-07

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

06

IMCAS Asia
Not Confirmed
arrow

08

IMCAS Asia
Not Confirmed
arrow
arrow
IMCAS Asia
Not Confirmed

MYCOPHENOLATE MOFETIL

NDC Package Code : 51927-5125

Start Marketing Date : 2020-12-14

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

09

IMCAS Asia
Not Confirmed
arrow
arrow
IMCAS Asia
Not Confirmed

MYCOPHENOLATE MOFETIL

NDC Package Code : 47848-019

Start Marketing Date : 2021-05-14

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

10

IMCAS Asia
Not Confirmed
arrow
arrow
IMCAS Asia
Not Confirmed

MYCOPHENOLATE MOFETIL

NDC Package Code : 65050-2101

Start Marketing Date : 2021-01-05

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

Looking for 128794-94-5 / Mycophenolate Mofetil API manufacturers, exporters & distributors?

Mycophenolate Mofetil manufacturers, exporters & distributors 1

35

PharmaCompass offers a list of Mycophenolate Mofetil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mycophenolate Mofetil manufacturer or Mycophenolate Mofetil supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mycophenolate Mofetil manufacturer or Mycophenolate Mofetil supplier.

PharmaCompass also assists you with knowing the Mycophenolate Mofetil API Price utilized in the formulation of products. Mycophenolate Mofetil API Price is not always fixed or binding as the Mycophenolate Mofetil Price is obtained through a variety of data sources. The Mycophenolate Mofetil Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Mycophenolate Mofetil

Synonyms

128794-94-5, Cellcept, 115007-34-6, Rs 61443, Myfenax, Rs-61443

Cas Number

128794-94-5

Unique Ingredient Identifier (UNII)

9242ECW6R0

About Mycophenolate Mofetil

Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION.

Mycophenolate mofetil Teva Manufacturers

A Mycophenolate mofetil Teva manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mycophenolate mofetil Teva, including repackagers and relabelers. The FDA regulates Mycophenolate mofetil Teva manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mycophenolate mofetil Teva API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Mycophenolate mofetil Teva manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Mycophenolate mofetil Teva Suppliers

A Mycophenolate mofetil Teva supplier is an individual or a company that provides Mycophenolate mofetil Teva active pharmaceutical ingredient (API) or Mycophenolate mofetil Teva finished formulations upon request. The Mycophenolate mofetil Teva suppliers may include Mycophenolate mofetil Teva API manufacturers, exporters, distributors and traders.

click here to find a list of Mycophenolate mofetil Teva suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Mycophenolate mofetil Teva NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Mycophenolate mofetil Teva as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Mycophenolate mofetil Teva API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Mycophenolate mofetil Teva as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Mycophenolate mofetil Teva and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Mycophenolate mofetil Teva NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Mycophenolate mofetil Teva suppliers with NDC on PharmaCompass.

Mycophenolate mofetil Teva Manufacturers | Traders | Suppliers

Mycophenolate mofetil Teva Manufacturers, Traders, Suppliers 1
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.